Associate Principal Scientist AstraZeneca Cambridge, United Kingdom
Join Annette Bak, Silvia Sonzini, and several authors in Poster Forum #7 in the Solution Center for a conversation about posters on the topic, “Drug Delivery for New and Existing Modalities”, that they are especially excited about.
T1230-08-54 Development of 3D-Printed Bicompartmental Tablets by Dual Fused Deposition Modelling (FDM) for Site-Specific Colon Drug Delivery, Isidoro Caraballo, Universidad de Sevilla
M0930-02-11 Exploring Phenylboronic Acid Conjugated pH-Sensitive Liposomes for Targeted Codelivery of Cisplatin-Chlorambucil Prodrug and Venetoclax for Triple-Negative Breast Cancer Management, Oly Katari, MS Pharm, National Institute of Pharmaceutical Education and Research
T1130-11-74 Multi-targeted Nanomedicine with Synergistic Doxorubicin and Oligo Hyaluronic Acid for Enhancing Anti-tumor Immunity in the Metastatic Triple-Negative Breast Cancer, Pei Zhi, BS, University of Toronto
T1230-01-03 Novel Expandable Platform for Retentive Drug Delivery Systems, Matteo Cerea, Ph.D., Universita degli Studi di Milano
W1130-02-12 Polydopamine-Coated Nanoparticles as a Targeted Drug Delivery System for the Treatment of Helicobacter pylori-Infected Gastric Ulcer, Hyunwoo Kim, Pharm.D., Pusan National University
W0930-02-13 Size-Dependent Drug Loading, Gene Complexation, Cell Uptake, and Transfection of a Novel Dendron-Lipid Nanoparticle for Drug/Gene Co-delivery, Kaila Javius-Jones, BS, University of Wisconsin Madison